Study of Teverelix DP on Prostate Volume, Urinary Function and Clinical Outcomes Following Acute Urinary Retention

NCT07733934 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Urinary Retention
Benign Prostate Hypertrophy(BPH)

Interventions

DRUG: Teverelix DP
DRUG: Teverelix DP Placebo
DRUG: Teverelix DP
DRUG: Teverelix DP Placebo

Sponsor

Antev Ltd.